Milestone Scientific Inc. Announces Pricing of $3.0 Million Public Offering of Common Stock
ROSELAND, N.J., Dec. 10, 2023 (GLOBE NEWSWIRE) — Milestone Scientific Inc. (NYSE:MLSS), a leading developer of computerized drug delivery instruments that provide painless and precise injections, today announced the pricing of an underwritten public offering of 4,765,000 shares of its common stock at a price of $0.63 per share (the “Offering”). Gross proceeds before underwriting discounts and commissions and estimated Offering expenses are expected to be approximately $3.0 million. The Offering is expected to close on December 13, 2023, subject to customary closing conditions.
Related news for (MLSS)
- Milestone Scientific Appoints Jason Papes as Senior Vice President, Global Head of Sales and Marketing
- MoBot’s Stock Market Highlights – 08/04/25 12:00 PM
- Milestone Scientific Appoints Highly Accomplished MedTech Executive Shanth Thiyagalingam to Board of Directors
- Milestone Scientific Reports Year-End 2024 Financial Results and Reports Strong Outlook for 2025
- Milestone Scientific Expands CompuFlo® Epidural System Footprint with InfiniSurg, LLC in New Jersey
